Randomized Trial: Trifluridine/Tipiracil in Patients with Heavily Pretreated Metastatic Gastric Cancer
13 Dec, 2018 | 18:07h | UTCTrifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentary: Trifluridine/Tipiracil in Heavily Pretreated Metastatic Gastric Cancer – The ASCO Post (free)